Enokizumab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IL9 |
| Identifiers | |
| ATC code | none |
| ChemSpider | none |
| UNII | I4BE5F78HR  |
| Chemical data | |
| Formula | C6492H10000N1704O2038S44 |
| Molar mass | 148.4 kg/mol |
 (what is this?) (verify) |
|
Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.[1]
Enokizumab was developed by MedImmune.
References[edit]
- ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Enokizumab" (PDF). American Medical Association.
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
